PARP Inhibition Sensitizes Breast Cancer Cells to Eribulin
Background: Poly(ADP-ribose) polymerases 1 and 2 (PARP1, 2), and 3 mediate protein modifications that facilitate the recruitment of DNA repair factors to single and double strand breaks. PARP3 is unique in that it is also required for efficient mitotic progression and stabilization of the mitotic sp...
Main Authors: | Bahram Sharif-Askari, Lawrence Panasci, Raquel Aloyz |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2023-03-01
|
Series: | Frontiers in Bioscience-Landmark |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/FBL/28/3/10.31083/j.fbl2803052 |
Similar Items
-
Stathmin dynamics modulate the activity of eribulin in breast cancer cells
by: Mikihiro Yoshie, et al.
Published: (2021-08-01) -
Simultaneous inhibition of ATR and PARP sensitizes colon cancer cell lines to irinotecan
by: Atlal eAbu-Sanad, et al.
Published: (2015-07-01) -
Activity of Eribulin in a Primary Culture of Well-Differentiated/Dedifferentiated Adipocytic Sarcoma
by: Alessandro De Vita, et al.
Published: (2016-12-01) -
Eribulin in Cancer Treatment
by: Umang Swami, et al.
Published: (2015-08-01) -
OLAPARIB: A promising PARP Inhibitor for the treatment of ovarian cancer
by: Soupos Nikolaos, et al.
Published: (2015-09-01)